Status:
RECRUITING
MSC Exosome Therapy for Post-Preeclampsia Endothelial Dysfunction
Lead Sponsor:
Universitas Padjadjaran
Collaborating Sponsors:
Dr. Hasan Sadikin General Hospital, Bandung, Indonesia
Dr Cipto Mangunkusumo General Hospital
Conditions:
Preeclampsia
Postpartum
Eligibility:
FEMALE
18-50 years
Phase:
PHASE1
PHASE2
Brief Summary
\--- Why Is This Study Being Done? Women who have preeclampsia during pregnancy face a much higher risk of heart disease later in life. Preeclampsia is a serious pregnancy condition that causes high...
Detailed Description
\--- Background and Rationale Preeclampsia affects 3-5% of pregnancies globally and represents a severe pregnancy-specific syndrome characterized by widespread maternal endothelial dysfunction. The ...
Eligibility Criteria
Inclusion
- Postpartum
- Confirmed diagnosis of preeclampsia in the last pregnancy
- Postpartum period of first week and second week
- Able to provide informed consent
Exclusion
- History of chronic hypertension prior to pregnancy
- Major cardiovascular disease history
- Active systemic infection
- Endothelial Injury history
- Active smoking status including vape, alcohol, drug addiction.
Key Trial Info
Start Date :
July 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT07183384
Start Date
July 1 2024
End Date
September 1 2026
Last Update
September 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr. Hasan Sadikin Central General Hospital
Bandung, West Java, Indonesia, 40161